UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
WASHINGTON
D.C. 20549
FORM
8-K
CURRENT
REPORT
Pursuant
to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of
Report (Date of Earliest Event Reported): April 7, 2010
WEIKANG
BIO-TECHNOLOGY
GROUP
CO., INC.
|
(Exact
name of registrant as specified in its
charter)
|
Nevada
|
333-165684
|
26-2816569
|
(State
or other jurisdiction of
|
(Commission
File Number)
|
(IRS
Employer Identification No.)
|
incorporation
or organization)
|
No. 365
Chengde Street, Daowai District, Harbin
Heilongjiang
Province, PRC 150020
(Address
of principal executive offices)
(86) 451
8835 5530
(Registrant’s
telephone number, including area code)
N/A
(Former
name or former address, if changed since last report)
Check the
appropriate box below if the Form 8-K filing is intended to simultaneously
satisfy the filing obligation of the registrant under any of the following
provisions (see
General Instruction A.2. below):
o
|
Written
communications pursuant to Rule 425 under the Securities Act (17 CFR
230.425)
|
o
|
Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
240.14a-12)
|
o
|
Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR
240.14d-2(b))
|
o
|
Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR
240.13e-4(c))
|
Item
5.02
|
Departure
of Directors or Certain Officers; Election of Directors; Appointment of
Certain Officers; Compensatory Arrangements of Certain
Officers.
|
On April
7, 2010, Wei Wang, Guangxin Wang, Yuanyuan Jing and Weili Wang resigned as
directors of the Company. Wei Wang, Guangxin Wang, Yuanyuan Jing and
Weili Wang’s resignations were due to personal reasons and not because of any
disagreement with the Company on any matter relating to the Company’s
operations, policies or practices.
On April
7, 2010, the board of directors (the “Board”) of Weikang Bio-Technology Group
Co., Inc. (the “Company”) appointed Yvonne Zhang, Yilun Jin, Allen Zhang and Yan
Huang as directors of the Company, effective immediately. The Board
has determined that Yvonne Zhang, Yilun Jin, Allen Zhang and Yan Huang are
independent directors within the meaning set forth in the applicable rules, as
currently in effect. In connection with the appointments of the new
directors to the Board, the Company has agreed to pay (i) Yvonne Zhang an annual
compensation of 10,000 shares of the Company’s restricted common stock, (ii)
Yilun Jin an annual compensation of 10,000 shares of the Company’s restricted
common stock, (iii) Allen Zhang an annual compensation of 10,000 shares of the
Company’s restricted common stock and (iv) Yan Huang an annual compensation of
10,000 shares of the Company’s restricted common stock. The biographical
information regarding each of the new directors is listed below:
Ms. Zhang
is a U.S. Certified Public Accountant. From November 2001 to June
2005, Ms. Zhang was the Accounting Manager of Koo Chow & Company, LLP, an
accounting firm in Los Angeles, CA. Ms. Zhang also served as the
Audit in Charge in Kabani & Company in Los Angeles, CA, from June 2005 to
June 2006. In addition, in July 2006, Ms. Zhang established her own
business, V-Trust Accounting and Tax Services, in Alhambra, CA, providing
consulting services to Chinese based companies going public in the U.S.
regarding Chinese GAAP and U.S. GAAP reconciliation, preparation of financial
statements in compliance with U.S. GAAP and PCAOB standards and review of
financial sections of SEC filings. Since August 2007, Ms. Zhang has
been serving as the Chief Financial Officer of Songzai International Holding
Group Inc., a coal production and mining company. Ms. Zhang received
her Bachelor degree in accounting in 1999 and her Master degree from California
State University, Northridge.
Mr. Jin
is a certified Chartered Financial Analyst. From August 2002 to
December 2003, Mr. Jin was the Management Associate of Citigroup in New York,
NY. Mr. Jin then served as the Vice President of Markets and Banking
of Citigroup in New York, NY, from January 2004 to September 2008. Since
September 2008, Mr. Jin has been serving as the Chief Financial Officer of
American Lorain Corporation, an integrated food manufacturing company, listed on
NYSE Amex. Mr. Jin received his Bachelor of Arts degree in Economics
from Fudan University, Shanghai, China in 1997 and his MBA in International
Management with Specialization of Finance from Thunderbird School of Global
Management in 2002.
Mr. Zhang
has been serving as the International Business Consultant of Oriental
Connections/China Railway Construction 18th Bureau
Corporation/Shanghai Power Transmission Engineering Company since 2002. Since
2008, Mr. Zhang also has been serving as the Interim Chief Financial Officer of
Pansoft Company Limited, an enterprise resource planning (ERP) software
solutions and services provider for the oil and gas industry in
China. Mr. Zhang received his Bachelor of Science degree in Economics
from People’s University of China, Beijing, China in 1982 and his Master of
Science in Agricultural and Applied Economics from University of Minnesota in
1988.
Ms. Huang
is a PRC qualified lawyer. From 1988 to 1992, Ms. Huang participated
in the professional business trainings of the copyright law, real estate law,
mergers and acquisitions and reorganization. She studied the Russian
trade regulations in Moscow in 1993. In 2003, Ms. Huang was awarded
the qualification of independent director of listed companies by Chinese
Securities Regulatory Commission. Ms. Huang is the founder and the attorney of
Heilongjiang Long Yang Law Firm, China, since 2007. Ms. Huang
received her Bachelor of Law degree and Master of Civil and Commercial Law
degree from Heilongjiang University in 1987.
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has
duly caused this report to be signed on its behalf by the undersigned hereunto
duly authorized.
WEIKANG
BIO-TECHNOLOGY
GROUP
CO., INC.
|
|||
Date:
April 12, 2010
|
By:
|
/s/
Yin Wang
|
|
Yin
Wang
Chief
Executive Officer
|
|||